Trial Watch: experimental TLR7/TLR8 agonists for oncological indications

Resiquimod (R848) and motolimod (VTX-2337) are second-generation experimental derivatives of imiquimod, an imidazoquinoline with immunostimulatory properties originally approved by the US Food and Drug Administration for the topical treatment of actinic keratosis and genital warts more than 20 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Frega, Giorgio, Wu, Qi, Le Naour, Julie, Vacchelli, Erika, Galluzzi, Lorenzo, Kroemer, Guido, Kepp, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466852/
https://www.ncbi.nlm.nih.gov/pubmed/32934889
http://dx.doi.org/10.1080/2162402X.2020.1796002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466852/
https://www.ncbi.nlm.nih.gov/pubmed/32934889
http://dx.doi.org/10.1080/2162402X.2020.1796002

Ejemplares similares